About Biotech Business with Fexingo: Life Sciences Startups, Drug Discovery, and FDA Approvals
Lucas and Luna step into the clean, cool world of biotechnology startups, where drug discovery meets the harsh realities of FDA approvals and venture capital. Each episode takes a single biotech company—from Moderna to a tiny CRISPR spinout—and dissects its science, its business model, and the regulatory path that determines its fate. Lucas brings the numbers: clinical trial phases, patent cliffs, burn rates. Luna presses on the human stories: the researchers betting careers on a single molecule, the patients waiting for therapies that might never come. They don't celebrate hype; they ask whether the science holds up, whether the market exists, and whether the FDA will say yes. Listeners will walk away able to read a biotech 10-K, understand a Phase II readout, and spot the difference between a genuine breakthrough and a stock promotion. How do you value a company with no revenue and a 90% chance of failure?
#Biotech #Lifesciences #DrugDiscovery #FDAApprovals #ClinicalTrials #Startups #VentureCapital #Pharma #Genomics #CRISPR #Therapeutics #RegulatoryScience #Patents #Investment #Business #FexingoBusiness #BusinessPodcast #Technology
Keep every episode free: buymeacoffee.com/fexingo (https://buymeacoffee.com/fexingo)
We dissect how artificial intelligence is reshaping biotech startup economics in Q4 2026. While the narrative promises faster drug discovery, the reality involves massive capital expenditure on compute and data licensing that is squeezing early-stage margins. We examine the specific tension between algorithmic efficiency and biological complexity, using concrete examples from recent patent filings and lab infrastructure investments to show why the 'AI miracle' isn't yet translating to linear valuation growth for pre-clinical ventures.
#BiotechStartups #AIDrugDiscovery #LifeSciences #VentureCapital #ComputationalBiology #BioTechEconomics #FDAApprovals #DataLicensing #LabInfrastructure #StartupValuation #MachineLearning #PharmaPartnerships #FexingoBusiness #BusinessPodcast #TechInvesting #ScientificInnovation #Q42026Markets #DeepTech
Keep every episode free: buymeacoffee.com/fexingo (https://buymeacoffee.com/fexingo)
23 Oct 2026
How Biotech Startups Secure Non-Dilutive Funding
Most biotech founders chase venture capital, but the smartest ones are quietly securing millions in non-dilutive grants and prizes. In this episode, we break down how companies like Moderna leveraged BARDA contracts to survive the pandemic, and how early-stage startups can use SBIR grants and innovation prizes to fund their first clinical trials without giving up equity. We explore the mechanics of these funding instruments, the hidden costs of grant compliance, and why the current high-interest-rate environment makes non-dilutive capital more attractive than ever for life sciences entrepreneurs.
#BiotechFunding #NonDilutiveCapital #SBIRGrants #BARDA #VentureCapital #LifeSciences #StartupStrategy #FDAApprovals #ClinicalTrials #DrugDiscovery #EquityFinancing #GovernmentContracts #InnovationPrizes #PharmaPartnerships #DeepTech #BusinessPodcast #FexingoBusiness #Economics
Keep every episode free: buymeacoffee.com/fexingo (https://buymeacoffee.com/fexingo)
19 Oct 2026
How Biotech Startups Are Fixing Their Broken Supply Chains
Biotech startups often fail not because their science is bad, but because they cannot manufacture it at scale. In this episode, Lucas and Luna explore the hidden bottleneck of cold-chain logistics and why companies like Moderna had to build their own manufacturing infrastructure from scratch. We examine how a single broken link in the supply chain can derail years of research, the rise of vertical integration in life sciences, and what founders must do to protect their product before Phase Three trials begin.
#BiotechStartups #SupplyChainLogistics #ColdChainManagement #ManufacturingScale #LifeSciencesInnovation #PharmaceuticalIndustry #BusinessStrategy #OperationalExcellence #VentureCapital #DrugDevelopment #FexingoBusiness #BusinessPodcast #TechEntrepreneurs #GlobalTrade #InnovationEconomics #StartupGrowth #RiskManagement #LucasAndLuna
Keep every episode free: buymeacoffee.com/fexingo (https://buymeacoffee.com/fexingo)
Contact Biotech Business with Fexingo: Life Sciences Startups, Drug Discovery, and FDA Approvals
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Biotech Business with Fexingo: Life Sciences Startups, Drug Discovery, and FDA Approvals?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
